Cargando…

Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients

BACKGROUND: Hypercoagulability and hypofibrinolysis are among the symptoms exhibited by diabetic patients. Our study aimed to address the polymorphic nature of Alu DNA fragment in the human tissue plasminogen activator gene within diabetes mellitus (DM) Jordanian patients. METHODS: Genomic DNA was i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasin, Salem R., AlHawari, Hussam H., Alassaf, Abeer A., Khadra, Maysa M., Al-Mazaydeh, Zainab A., Al-Emerieen, Ala'a F., Tahtamouni, Lubna H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pasteur Institute of Iran 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800539/ https://www.ncbi.nlm.nih.gov/pubmed/31104419 http://dx.doi.org/10.29252/ibj.23.6.423

Ejemplares similares

Alu-repeat polymorphism in the tissue plasminogen activator (t-PA) gene, seminal t-PA concentration, and male fertility impairment: A case-control study
por: Tahtamouni, Lubna Hamid, et al.
Publicado: (2020)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise
por: COUGHLIN, ADAM M., et al.
Publicado: (2018)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)

Tissue plasminogen activator (tPA) attenuates propofol-induced apoptosis in developing hippocampal neurons
por: Liang, Chao, et al.
Publicado: (2016)

Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release
por: Varangot, Alexandre, et al.
Publicado: (2023)

Anti-spermatogenic activities of Taraxacum officinale whole plant and leaves aqueous extracts
por: Tahtamouni, Lubna Hamid, et al.
Publicado: (2016)

Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR
por: Bertrand, T, et al.
Publicado: (2015)

PS88. Association between Alu insertion/deletion polymorphism on the tPA gene and mirtazapine response in Koreans with major depression
por: Kim, Daseul, et al.
Publicado: (2016)

To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019)

Enhanced control of bioactivity of tissue plasminogen activator (tPA) through domain-directed enzymatic oxidation of terminal galactose
por: Mahdi, Wael A., et al.
Publicado: (2022)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease
por: Tao, Yanyi, et al.
Publicado: (2023)

Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate
por: Jeanneret, Valerie, et al.
Publicado: (2016)

The Association of 3-Hydroxy-3-Methylglutaryl-CoA Reductase, Apolipoprotein E, and Solute Carrier Organic Anion Genetic Variants with Atorvastatin Response among Jordanian Patients with Type 2 Diabetes
por: Alhawari, Hussam, et al.
Publicado: (2020)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
por: Mennesson, Marie, et al.
Publicado: (2023)

PSUN171 CORRELATIONS BETWEEN SERUM AND TEAR PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE PLASMINOGEN ACTIVATOR (tPA) IN PATIENTS WITH DIABETIC RETINOPATHY
por: Jasmiad, Nurbadriah, et al.
Publicado: (2022)

PACAP Interacts with PAC(1) Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures
por: Castorina, Alessandro, et al.
Publicado: (2015)

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer
por: Witte, J H de, et al.
Publicado: (1999)

Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
por: Boone, Niels Willem, et al.
Publicado: (2012)

Regulated Proteolytic Processing of Reelin through Interplay of Tissue Plasminogen Activator (tPA), ADAMTS-4, ADAMTS-5, and Their Modulators
por: Krstic, Dimitrije, et al.
Publicado: (2012)

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

The effect of prehospital notification by emergency medical service on outcomes in patients receiving recombinant tissue-type plasminogen activator (r-tPA)
por: Rafie, Shahram, et al.
Publicado: (2022)

Double-Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro
por: Song, Shaozheng, et al.
Publicado: (2022)

Low-Dose Slow Infusion Tissue Plasminogen Activator (tPA) in Treatment of Thrombotic Coronary Artery Occlusions: Case Series and Literature Review
por: Akçay, Murat, et al.
Publicado: (2022)

Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke
por: Lapchak, Paul A, et al.
Publicado: (2014)

Unintentional intramuscular administration of tPA/DNase for pleural infection
por: Popowicz, Natalia, et al.
Publicado: (2014)

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
por: Khalil, Sara, et al.
Publicado: (2023)

l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
por: Yang, Juan, et al.
Publicado: (2023)

The Battle Against COVID-19 in Jordan: An Early Overview of the Jordanian Experience
por: Al-Tammemi, Ala'a B.
Publicado: (2020)

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
por: Whyte, Claire S., et al.
Publicado: (2021)

The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007–2012)
por: Tomlinson, J.E., et al.
Publicado: (2015)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19
por: Carneiro, Thiago, et al.
Publicado: (2020)

Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
por: Roy, Bapti, et al.
Publicado: (2020)

NF-κB and tPA Signaling in Kidney and Other Diseases
por: White, Samantha, et al.
Publicado: (2020)

721 Defining Bleeding Characteristics in Frostbite Patients Managed with tPA
por: Murphy, Jenna E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nq1fks6l3t21a8bl9upn503bg1